Opinion: Banning Shark Fin Sales in the U.S. Will Backfire

A proposal to do so would cause waste, promote less sustainable fisheries, and penalize US fishers who follow best practices.

Written byRobert Hueter
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

COURTESY MOTE MARINE LABT

The proposed Shark Fin Sales Elimination Act of 2017, currently being considered by Congress, is supported by a number of conservation groups. This bill proposes to eliminate all trade in shark fins within the U.S. to solve the problem of global shark declines. As someone with more than 40 years of experience in shark science and conservation, I am dedicated to the cause of rebuilding our depleted shark populations. But I believe that banning the sale of fins within the U.S. will be ineffective in protecting sharks.

Robert HueterCOURTESY MOTE MARINE LABThe proposed Act states that “no person shall possess, transport, offer for sale, sell, or purchase shark fins or products containing shark fins,” with a few specific exceptions. The Act is not focused on shark “finning,” which is the inhumane, wasteful practice of removing a shark’s fins at sea and tossing the animal back to die. Finning has been illegal in U.S. waters since the 1990s.

These days, U.S. shark fisheries are managed carefully for sustainability, based on scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies